Agency Forms Undergoing Paperwork Reduction Act Review, 67759-67760 [2015-27890]
Download as PDF
<![CDATA[
67759
Federal Register / Vol. 80, No. 212 / Tuesday, November 3, 2015 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–27888 Filed 11–2–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–16–0824]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
BioSense (OMB Control No. 0920–
0824, Expiration 11/30/2015)—
Revision—Center for Surveillance,
Epidemiology and Laboratory Services
(CSELS), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The BioSense Program was created by
congressional mandate as part of the
Public Health Security and Bioterrorism
Preparedness and Response Act of 2002
and was launched by the CDC in 2003.
The original BioSense Program
(BioSense 1.0) was intended to serve as
a national level public health syndromic
surveillance system for early detection
and rapid assessment of potential
bioterrorism-related illness and injury.
In 2009, CDC began planning and
developing the computing cloud-based
BioSense 2.0 Platform. This cloud-based
system would offer secure storage space
for data and data sharing capacity for
each state and local health department.
Since August 2012, when CDC
submitted a request to OMB for
approval of a revision to the BioSense
information collection request, HHS
published new guidance on Meaningful
Use of Electronic Health Records for
syndromic surveillance. During this
time, CDC also initiated its new CDC
Surveillance Strategy. These actions
provided new guidance for
improvements to the BioSense Program,
which resulted in new requirements for
data submission to the BioSense
Platform and new requests specified
below.
CDC requests a three-year Revision
approval for BioSense. This Revision
includes new requests for approval to:
(1) Change the title of the information
collection request from BioSense to the
National Syndromic Surveillance
Program (NSSP); (2) receive data from
additional state, local, and territorial
health departments; (3) receive from
state, local, and territorial health
departments syndromic surveillance
data submitted to those health
departments from urgent care,
ambulatory care and hospital inpatient
settings (in addition to data from
hospital emergency departments,
included in the previously approved
information collection request); and (4)
receive from state, local, and territorial
health departments additional
syndromic surveillance data elements.
The total estimated number of burden
hours has decreased since the
previously approved information
collection request because we
inadvertently included estimates for the
Department of Defense, Department of
Veterans Affairs, and the two
organizations that provide pharmacy
data. We only included estimates for
state, local, and territorial public health
jurisdictions and the private sector
laboratory company that provides
laboratory data free of charge to CDC in
this information collection request.
There is no burden for the private sector
laboratory company for recruitment,
registration, and healthcare data
collection. The private sector laboratory
company chose their sharing
permissions when they registered to use
the system. The estimated annual
burden is 39 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
mstockstill on DSK4VPTVN1PROD with NOTICES
Type of respondents
Form name
State, Local and Territorial Public Health Departments
State, Local and Territorial Public Health Departments
State, Local, and Territorial Public Health Departments
Recruitment Information Collection
Registration Information Collection
Healthcare Information Collection:
Administrator
Data
Sharing
Agreements/Permissions.
VerDate Sep<11>2014
18:04 Nov 02, 2015
Jkt 238001
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
E:\FR\FM\03NON1.SGM
Number of
responses per
respondent
20
200
20
03NON1
1
1
1
Average
burden per
response
(in hrs.)
1
5/60
5/60
67760
Federal Register / Vol. 80, No. 212 / Tuesday, November 3, 2015 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–27890 Filed 11–2–15; 8:45 am]
BILLING CODE 4163–18–P
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–15–0960]
mstockstill on DSK4VPTVN1PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
VerDate Sep<11>2014
18:04 Nov 02, 2015
Jkt 238001
Epidemiologic Study of Health Effects
Associated With Low Pressure Events in
Drinking Water Distribution Systems
(OMB Control No. 0920–0960,
expiration 3/31/2016)—Extension—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
In the United States (U.S.), drinking
water distribution systems are designed
to deliver safe, pressurized drinking
water to our homes, hospitals, schools
and businesses. However, the water
distribution infrastructure is 50–100
years old in much of the U.S. and an
estimated 240,000 water main breaks
occur each year. Failures in the
distribution system such as water main
breaks, cross-connections, back-flow,
and pressure fluctuations can result in
potential intrusion of microbes and
other contaminants that can cause
health effects, including acute
gastrointestinal and respiratory illness.
Approximately 200 million cases of
acute gastrointestinal illness occur in
the U.S. each year, but we lack reliable
data to assess how many of these cases
are associated with drinking water.
Further, data are even more limited on
the human health risks associated with
exposure to drinking water during and
after the occurrence of low pressure
events (such as water main breaks) in
drinking water distribution systems. A
study conducted in Norway from 2003–
2004 found that people exposed to low
pressure events in the water distribution
system had a higher risk for
gastrointestinal illness. A similar study
is needed in the United States.
The purpose of this data collection is
to conduct an epidemiologic study in
the U.S. to assess whether individuals
exposed to low pressure events in the
water distribution system are at an
increased risk for acute gastrointestinal
or respiratory illness. This study would
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
be, to our knowledge, the first U.S.
study to systematically examine the
association between low pressure events
and acute gastrointestinal and
respiratory illnesses. Study findings will
inform the Environmental Protection
Agency (EPA), CDC, and other drinking
water stakeholders of the potential
health risks associated with low
pressure events in drinking water
distribution systems and whether
additional measures (e.g., new
standards, additional research, or policy
development) are needed to reduce the
risk for health effects associated with
low pressure events in the drinking
water distribution system.
We will conduct a cohort study
among households that receive water
from six water utilities across the U.S.
The water systems will be
geographically diverse and will include
both chlorinated and chloraminated
systems. These water utilities will
provide information about low pressure
events that occur during the study
period using a standardized form
(approximately 11 events per utility).
Utilities will provide address listings of
households in areas exposed to the low
pressure event and comparable
households in an unexposed area to
CDC staff, who will randomly select
participants and send them an
introductory letter and questionnaire.
Consenting household respondents will
be asked about symptoms and duration
of any recent gastrointestinal or
respiratory illness, tap water
consumption, and other exposures
including international travel, daycare
attendance or employment, animal
contacts, and recreational water
exposures. Study participants may
choose between two methods of survey
response: A mail-in paper survey and a
Web-based survey.
Participation in this study will be
voluntary. No financial compensation
will be provided to study participants.
The study duration is anticipated to last
30 months. An estimated 6,750
individuals will be contacted and we
anticipate 4,050 utility customers (18
years of age or older) will consent to
participate in this study. The total
estimated annualized hours associated
with this study is expected to be 548.
There are no costs to respondents
other than their time.
E:\FR\FM\03NON1.SGM
03NON1
]]>Agencies
[Federal Register Volume 80, Number 212 (Tuesday, November 3, 2015)]
[Notices]
[Pages 67759-67760]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-27890]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-16-0824]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
BioSense (OMB Control No. 0920-0824, Expiration 11/30/2015)--
Revision--Center for Surveillance, Epidemiology and Laboratory Services
(CSELS), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The BioSense Program was created by congressional mandate as part
of the Public Health Security and Bioterrorism Preparedness and
Response Act of 2002 and was launched by the CDC in 2003. The original
BioSense Program (BioSense 1.0) was intended to serve as a national
level public health syndromic surveillance system for early detection
and rapid assessment of potential bioterrorism-related illness and
injury. In 2009, CDC began planning and developing the computing cloud-
based BioSense 2.0 Platform. This cloud-based system would offer secure
storage space for data and data sharing capacity for each state and
local health department. Since August 2012, when CDC submitted a
request to OMB for approval of a revision to the BioSense information
collection request, HHS published new guidance on Meaningful Use of
Electronic Health Records for syndromic surveillance. During this time,
CDC also initiated its new CDC Surveillance Strategy. These actions
provided new guidance for improvements to the BioSense Program, which
resulted in new requirements for data submission to the BioSense
Platform and new requests specified below.
CDC requests a three-year Revision approval for BioSense. This
Revision includes new requests for approval to: (1) Change the title of
the information collection request from BioSense to the National
Syndromic Surveillance Program (NSSP); (2) receive data from additional
state, local, and territorial health departments; (3) receive from
state, local, and territorial health departments syndromic surveillance
data submitted to those health departments from urgent care, ambulatory
care and hospital inpatient settings (in addition to data from hospital
emergency departments, included in the previously approved information
collection request); and (4) receive from state, local, and territorial
health departments additional syndromic surveillance data elements.
The total estimated number of burden hours has decreased since the
previously approved information collection request because we
inadvertently included estimates for the Department of Defense,
Department of Veterans Affairs, and the two organizations that provide
pharmacy data. We only included estimates for state, local, and
territorial public health jurisdictions and the private sector
laboratory company that provides laboratory data free of charge to CDC
in this information collection request. There is no burden for the
private sector laboratory company for recruitment, registration, and
healthcare data collection. The private sector laboratory company chose
their sharing permissions when they registered to use the system. The
estimated annual burden is 39 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hrs.)
----------------------------------------------------------------------------------------------------------------
State, Local and Territorial Public Recruitment Information 20 1 1
Health Departments. Collection.
State, Local and Territorial Public Registration Information 200 1 5/60
Health Departments. Collection.
State, Local, and Territorial Public Healthcare Information 20 1 5/60
Health Departments. Collection:
Administrator Data
Sharing Agreements/
Permissions.
----------------------------------------------------------------------------------------------------------------
[[Page 67760]]
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-27890 Filed 11-2-15; 8:45 am]
BILLING CODE 4163-18-P
